KMTS (Kestra Medical Technologies, Inc.) Return on Sales by Gross Profit

KMTS (Kestra Medical Corp) - company brandmark

Kestra Medical Technologies controls assembly sterility at its own plants, utilizing external outsourcing for boards moderately. Gross margin reflects production efficiency, with the 53.90 mark recording this metric. The brand enjoys the trust of physicians as a creator of life-saving defibrillators. Stable sales of wearable devices guarantee an inflow of operating cash to support the company's current activities.

Kestra Medical Technologies (KMTS): Gross Margin from 03/07/2025 to 11/20/2026

Comprehensive metric breakdowns and analytics for Kestra Medical Technologies (KMTS)

Summary company analysis:Kestra Medical - KMTS
Finished products of Kestra Medical Corp

Gross margin measures production efficiency by determining the profit share of each unit of revenue after deducting direct product creation costs. An analysis of the trading gross margin allows for an assessment of Kestra Medical Technologies' resilience to electronics supply chain disruptions and logistical risks, confirming the issuer's ability to maintain profitability amid geopolitical instability.